J Clin Aesthet Dermatol. 2024;17(3):7–10. Pregnancy with Hidradenitis Suppurativa: What Do We Know About Obstetric and Fetal Outcomes? Dear Editor: Hidradenitis suppurativa (HS) is a chronic, inflammatory, debilitating skin disorder
J Clin Aesthet Dermatol. 2024;17(3):18–20. by Ayşe Akman-Karakaş, MD; Raza Khan, MD; and Amor Khachemoune, MD Dr. Akman-Karakas is with Akdeniz University’s School of Medicine Department of Dermatology and Venereology
J Clin Aesthet Dermatol. 2024;17(3):21–23. by Noureddine Litaiem, MD; Amel Chabbouh, MD; Ines Chabchoub, MD; Radhi Ben Naceur, MD; Mourad Mokni, MD; and Faten Zeglaoui, MD Drs. Litaiem, Chabbouh, Chabchoub,
J Clin Aesthet Dermatol. 2024;17(3):24–33. by Faraz Yousefian, DO; Ciaran Smythe, DO; Haowei Han, DO; Boni E Elewski, MD; and Mark Nestor MD, PhD Drs. Yousefian, Smythe, Han and Nestor
J Clin Aesthet Dermatol. 2024;17(3):34–41. by Toral Vaidya, MD, MPH; Lauren Hoffman, MD; and Anne Chapas, MD Dr. Vaidya is with the Weill Cornell Department of Dermatology in New York,
J Clin Aesthet Dermatol. 2024;17(3):42–47. FUNDING: No funding was provided for this article. DISCLOSURES: The authors have no conflicts of interest relevant to the contents of this article. by Iman
J Clin Aesthet Dermatol. 2024;17(3):48–51. by Joshua Zeichner, MD; Edward (Ted) Lain, MD, MBA; Kavita Mariwalla, MD; Tanja Bußmann, Dr; Julia M. Weise, Dr; Elisabeth Maaß; Andrea Krüger; Anne-Kathleen Schade; Frank
J Clin Aesthet Dermatol. 2024;17(2):15–19. by Zoe Diana Draelos, MD, FAAD; Pearl E. Grimes, MD, FAAD; Jacqueline Watchmaker, MD, FAAD; and Diane B. Nelson, RN, MPH Dr. Draelos is with
J Clin Aesthet Dermatol. 2024;17(2):20-22. by Yun Seok Yang, MD; Duk Han Kim, MD; Ji Hyun Ha, MD; Na Young Ko, MD; Joong Keun Kim, MD; Woo Jin Choi, MD;
J Clin Aesthet Dermatol. 2024;17(2):24–28. by Sheila C. Barbarino, MD, FACS; Doris Day, MD; Alexander Rivkin, MD; Jennifer Levine, MD; and John Fezza, MD Dr. Barbarino is with Barbarino Surgical
J Clin Aesthet Dermatol. 2024;17(2):30–31. by Raj Chovatiya, MD, PhD Dr. Chovatiya is with the Center for Eczema and Itch, Clinical Trials Unit at Northwestern University Feinberg School of Medicine
J Clin Aesthet Dermatol. 2024;17(2):32–42. by Blanca Estupiñan MD; Adam Souchik, MD; Alexandra Kiszluk, BS; and Shraddha Desai, MD Drs. Estupiñan, Souchik, and Desai are with the Division of Dermatology
J Clin Aesthet Dermatol. 2024;17(2):43–46. by Zoe Diana Draelos, MD, FAAD; Pearl E. Grimes, MD, FAAD; Jacqueline Watchmaker, MD, FAAD; and Diane B. Nelson, RN, MPH Dr. Draelos is with
J Clin Aesthet Dermatol. 2024;17(2):47–51. by Refaat R. Mohamed, MD; Leila Gallab Mahmoud Mohamed, MBBCh; Mofreh Mansour, MD; and Mahmoud A. Rageh, MD Drs. Refaat R. Mohamed, Mahmoud Mohamed, and
by Kasey D’Amato, PA-C, MPAP Ms. D’Amato is President of Certified PA Consulting in Ft. Lauderdale, Florida. J Clin Aesthet Dermatol. 2023;17(1–2 Suppl 1):S42–S43. FUNDING: No funding was provided for this
J Clin Aesthet Dermatol. 2024;17(1–2 Suppl 1):S33–S37. Atopic Dermatitis Efficacy and safety of roflumilast cream 0.15% in adults and children aged ≥6 with mild-to-moderate atopic dermatitis in two Phase III
J Clin Aesthet Dermatol. 2024;17(1–2 Suppl 1):S15–S30. Acne Early and sustained reductions in moderate-to-severe acne with fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel Presenters: Julie C.
Reactive Hyperhidrosis Induced by Topical Products Dear Editor: Hyperhidrosis (HH), a dermatologic condition characterized by sweat production beyond thermoregulatory needs, affects approximately five percent of the population in the United
J Clin Aesthet Dermatol. 2024;17(1):10–12. by Elizabeth Kudlaty, MD, MS; Phoebe Newell, MD; and Raj Chovatiya, MD, PhD Dr. Kudlaty is with the Division of Allergy and Immunology and the
J Clin Aesthet Dermatol. 2024;17(1):13–14. by Jay Patel, MD; Danielle Morin; BS, Ted Rosen, MD; Carina Wasko, MD; Leah Douglas, MD Drs. Patel, Rosen, Wasko, and Douglas are with the